Halozyme Therapeutics, Inc. (NASDAQ:HALO) SVP Sells $453,800.00 in Stock
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) SVP Michael J. Labarre sold 10,000 shares of Halozyme Therapeutics stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $45.38, for a total transaction of $453,800.00. Following the transaction, the senior vice president now directly owns 168,176 shares of […]
More Stories
bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Update
bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) was the target of a significant drop in short interest during the month...
Short Interest in Camden National Co. (NASDAQ:CAC) Expands By 31.5%
Camden National Co. (NASDAQ:CAC – Get Free Report) was the target of a significant increase in short interest during the...
Global X NASDAQ 100 Risk Managed Income ETF (NASDAQ:QRMI) Short Interest Up 48.8% in September
Global X NASDAQ 100 Risk Managed Income ETF (NASDAQ:QRMI – Get Free Report) saw a large growth in short interest...
Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Short Interest Update
Stronghold Digital Mining, Inc. (NASDAQ:SDIG – Get Free Report) was the recipient of a significant decrease in short interest in...
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY) Sees Large Increase in Short Interest
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY – Get Free Report) saw a significant growth in short interest in September. As of...
BTCS Inc. (NASDAQ:BTCS) Short Interest Update
BTCS Inc. (NASDAQ:BTCS – Get Free Report) was the target of a large decline in short interest in September. As...